Zilico was founded in 2006 following a successful collaboration between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, UK, to develop a more accurate means of diagnosis for cervical intraepithelial neoplasia (CIN).
The company has developed its patented Electrical Impedance Spectroscopy (EIS) into a platform technology for cancer diagnosis and is expanding its product development into other clinical areas. See Product Pipeline Page
Zilico's head office is located in Manchester, UK . Manufacturing and R&D functions are also carried out in the UK and Zilico achieved ISO 13485 accreditation in 2013.
Watch our Company Video
Following the release of its flagship product ZedScan in 2013, Zilico has appointed a number of international distributors.
The name Zilico
- Z (zeta) is the symbol for impedance, the all-important measure which underpins Zilico’s technology
- ilico is a Latin word meaning ‘on the spot’ or ‘immediate’: reflecting the benefit of Zilico’s diagnostic devices that deliver results in real time.